Dopamine-Agonist Induced Cerebrospinal Fluid Rhinorrhea; a Case Report

  • Hira Irfan Shaukat Khanum Memorial Cancer Hospital and Research centre
  • Ahmed Imran Siddiqi
  • Umal Azmat
  • Waqas Shafiq
  • Muhammad Atif Naveed
  • Irfan Yousaf
Keywords: piyuitary gland, cerebrospinal fluid rhinorrhea, dopamine agonists, prolactinoma, meningitis, transsphenoidal surgery, sphenoid sinus

Abstract

Introduction: Prolactinomas are the most common pituitary adenomas. Medical therapy with dopamine agonists (DA) is the mainstay of treatment and rarely requires surgical manipulation. Patients may rarely present with cerebrospinal fluid (CSF) rhinorrhea after starting therapy with DA in case of massive or invasive prolactinomas. Case Description: We present a case of a 29-year-old lady with invasive prolactinoma who presented with CSF rhinorrhea after a month of starting bromocriptine therapy with the development of meningitis and warranting early surgical repair. Practical Implications: Patients with macroprolactinoma should be closely monitored initially after starting on dopamine agonists to avoid life-threatening complications.

Published
2021-01-11
How to Cite
1.
Irfan H, Siddiqi AI, Azmat U, Shafiq W, Naveed MA, Yousaf I. Dopamine-Agonist Induced Cerebrospinal Fluid Rhinorrhea; a Case Report . J Cancer Allied Spec [Internet]. 2021Jan.11 [cited 2021Apr.17];7(1). Available from: https://journals.sfu.ca/jcas/index.php/jcas/article/view/389